ARCHIVES

IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies

This article is from The Cancer Letter archive.

Vol. 13 No. 19 | May 8, 1987

Download PDF Visit The Full Archive

Related Articles

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

Cancer Advocates Seek 6.5% Increase For NCI In Fiscal 1997

March 8, 1996

Psychiatric Society For Oncology/AIDS Formed; Holland Pres.

January 6, 1989

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

Erbitux Improves Survival In Advanced Colorectal Cancer

November 30, 2007

NCI To Establish New Offices for Special Populations, Survivorship, Klausner Tells House appropirations Subcommittee

May 3, 1996